Next Quarterly Earnings
Thursday, February 18, 2027
Expected
Telix Pharmaceuticals
Telix Pharmaceuticals is a leading Australian biopharmaceutical company specializing in the development of innovative radiopharmaceuticals. By focusing on molecular imaging and targeted cancer therapies, Telix improves the diagnosis and treatment of oncological diseases worldwide.
Frequently asked questions
When did Telix Pharmaceuticals last report quarterly earnings?
Telix Pharmaceuticals last reported quarterly earnings on 8/19/2026 (Q2 2026). Earnings per share (EPS) came in at 0.25 AUD.
How does Telix Pharmaceuticals stock react to earnings?
Across its last 3 earnings reports, Telix Pharmaceuticals stock moved by ±5.3% on average the following day. The largest reaction was -7.9% on 02/19/2026; 2 of 3 reactions were positive.
How do I add the Telix Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±5.3%
Avg. next-day move
-7.9%
Largest move (02/19/2026)
66.7%
Share of positive reactions
±11.3%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Telix Pharmaceuticals
Country
🇦🇺
More Financial Information